Divis Laboratories Ltd (DIVISLAB)
₹4113▲1.34%
Divis Laboratories Ltd share Performance
- ₹4,027.4₹4,127.55₹4113
2.08%
Low
Day's Volatility:2.43%
High
0.35%
- ₹3,221.05₹4,127.55₹4113
21.69%
Low
52 Weeks Volatility:22.04%
High
0.35%
| Returns % | |
| 1 Month Return | + 7.69 % |
| 3 Month Return | + 11.25 % |
| 1 Year Return | + 19.87 % |
| Market Stats | |
| Previous Close | ₹₹4,058.55 |
| Open | ₹₹4,060.00 |
| Volume | ₹6.93L |
| Upper Circuit | ₹- |
| Lower Circuit | ₹- |
| Market Cap | ₹₹1,07,741.75Cr |
Analyst Rating
based on 25 analysts
Based on 25 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹3442.36
Source: S&P Global Market Intelligence
Company Information
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Share Price: ₹4113.00 per share as on 23 May, 2024 04:01 PM
Market Capitalisation: ₹1,07,741.75Cr as of today
Revenue: ₹1,855.00Cr as on December 2023 (Q4 23)
Net Profit: ₹358.00Cr as on December 2023 (Q4 23)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Divis Laboratories Ltd
Divis Labs Likely to Be Excluded From Nifty50 Index - 17 May, 2024
According to analysts at Nuvama Alternative and Quantitative Research, Divis Laboratories is expected to be replaced by Bharat Electronics Ltd. and Trent Ltd. in the benchmark Nifty50 index during the upcoming reshuffle in September this year, leading to an outflow of $213 million.
Bullish Signal for Divis Laboratories Ltd Stock - 09 May, 2024
A bullish piercing candlestick pattern has emerged, indicating potential upward momentum. Investors may consider long positions within Rs 3,950-3,900 range with a target price of Rs 4,300 and stop-loss order near Rs 3,810 on daily closing basis.
Divis Laboratories Ltd Up 3.79% on NSE - 26 Apr, 2024
Divis Laboratories Ltd rose for the fifth straight session, up 3.79% to Rs 3989.3 on the NSE. The stock has added around 18.45% in the last month and is up 23.19% YoY. The Nifty Pharma index, of which Divis Laboratories is a constituent, is up 1.29% in the last month.
Divis Labs Plans Capacity Expansion at Manufacturing Facility - 25 Apr, 2024
Divis Laboratories is planning to invest up to Rs 700 crore in expanding its manufacturing facility and entering into a long-term supply agreement with a customer. The proposed facility is expected to be operational around January 2027.
Divis Laboratories Ltd has a high P/E ratio of 71.2x - 19 Apr, 2024
Despite declining earnings, Divis Laboratories Ltd's high P/E ratio of 71.2x is due to analysts predicting strong future growth. Shareholders are confident in the company's future earnings.
Fundamentals of Divis Laboratories Ltd
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 348.0 Cr → 358.0 Cr (in ₹), with an average increase of 2.8% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 13.72% to 14.28% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Zydus Lifesciences Ltd has given 113.0% return, outperforming this stock by 93.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.92% of holdings in Mar 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 122.8% return, outperforming this stock by 123.7%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 14.86% to 14.68% in Mar 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, DIVISLAB stock has moved down by -0.9%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.33% to 11.19% in Mar 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.99K Cr → 1.95K Cr (in ₹), with an average decrease of 2.3% per quarter
Divis Laboratories Ltd Valuation
Divis Laboratories Ltd in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (62.91x)
May 22, 2024
Today (77.88x)
May 22, 2024
Highest (78.53x)
December 28, 2023
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.92% | 0.00 | |
| Foreign Institutions | 14.68% | 0.00 | |
| Mutual Funds | 14.28% | 0.00 | |
| Retail Investors | 11.19% | 0.00 | |
| Others | 7.93% | 0.00 |
Technicals of Divis Laboratories Ltd share
News & Events of Divis Laboratories Ltd
News
Sweeping changes to America's aging power grid are on their way to help bypass NIMBY roadblocks and state infighting
The federal government in the last month has made sweeping changes to how upgrades to the power grid are planned, paid for, and permitted.
23 May, 2024 03:36 PMPower Grid Corp Shares Dip After Q4 Profit Decline
Shares of Power Grid Corporation fell by 2% following a nearly 4% dip in consolidated net profit for the March 2024 quarter. The stock closed at Rs 319.75 on th... Read more
23 May, 2024 04:38 PMPower Grid shares decline 2 pc after March quarter earnings
Shares of Power Grid Corporation on Thursday went lower 2 per cent after the company reported a nearly four per cent dip in its consolidated net profit in the .... Read more
23 May, 2024 04:40 PM
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Divis Laboratories Ltd shares.
Divis Laboratories Ltd (DIVISLAB) share price today is ₹4113
Divis Laboratories Ltd is listed on NSE
Divis Laboratories Ltd is listed on BSE
- Today’s highest price of Divis Laboratories Ltd is ₹4127.55.
- Today’s lowest price of Divis Laboratories Ltd is ₹4027.4.
PE Ratio of Divis Laboratories Ltd is 77.88
PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share
Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 6.93L.
Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹107741.75Cr.
| Divis Laboratories Ltd(DIVISLAB | Price |
|---|---|
52 Week High | ₹4127.55 |
52 Week Low | ₹3221.05 |
Divis Laboratories Ltd(DIVISLAB) share price is ₹4113. It is down -0.35% from its 52 Week High price of ₹4127.55
Divis Laboratories Ltd(DIVISLAB) share price is ₹4113. It is up 27.69% from its 52 Week Low price of ₹3221.05
| Divis Laboratories Ltd(DIVISLAB | Returns |
|---|---|
1 Day Returns | 54.45% |
1 Month Returns | 7.69% |
3 Month Returns | 11.25% |
1 Year Returns | 19.87% |